Mr Andrew Murphy and Radswiki et al.

Thorotrast is a radioactive radiographic contrast agent containing thorium dioxide first produced in Germany in 1928 and was in use until the 1950s. It was used primarily for cerebral angiography, and 90% of the estimated 50,000-100,000 patients who received it were studied for this purpose. 

The deposition of Thorotrast is dependant on its radiological use, preparation method, and the age of the preparation; however, the primary site is the reticuloendothelial system such as liver, spleen, bone marrow, lymph nodes. A plain radiograph of the abdomen demonstrates fine, irregular metallic densities distributed throughout the liver, spleen and parapancreatic lymph nodes 4

Thorotrast is carcinogenic with hepatic angiosarcomas being the classical thorotrast-related neoplasm. Other thorotrast-related neoplasms include:

Share article

Article information

rID: 12721
Section: Gamuts
Synonyms or Alternate Spellings:

Support Radiopaedia and see fewer ads

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.